bpc 157 oral vs injection pharmacokinetics Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157: Dosage, Benefits, FDA Status
Description
Similar results were obtained by Fraczek in 80 Polish athletes, where 2.5% of subjects did not achieve the level of Estimated Average Requirement, whereas the excessive intake of cobalamin was observed in 96.5% [38]
investigators considered them unrelated, but no long-term oncology safety data exists)
The excitement around this medication is impossible to ignore
However, most injections deliver between one and three months of relief
